Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
07/09/202317:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023NASDAQ:CDMOPAvid Bioservices Inc
31/08/202317:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023NASDAQ:CDMOPAvid Bioservices Inc
21/06/202318:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CDMOPAvid Bioservices Inc
21/06/202317:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
21/06/202317:07GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023NASDAQ:CDMOPAvid Bioservices Inc
14/06/202317:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023NASDAQ:CDMOPAvid Bioservices Inc
08/06/202320:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
10/05/202317:05GlobeNewswire Inc.Avid Bioservices to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
05/05/202320:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
04/04/202309:05GlobeNewswire Inc.Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future CustomersNASDAQ:CDMOPAvid Bioservices Inc
13/03/202317:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
06/03/202318:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023NASDAQ:CDMOPAvid Bioservices Inc
14/02/202314:44Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDMOPAvid Bioservices Inc
09/02/202313:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDMOPAvid Bioservices Inc
06/12/202218:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDMOPAvid Bioservices Inc
06/12/202218:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
29/11/202218:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022NASDAQ:CDMOPAvid Bioservices Inc
16/11/202210:05GlobeNewswire Inc.Avid Bioservices Appoints Oksana Lukash as Vice President, PeopleNASDAQ:CDMOPAvid Bioservices Inc
02/11/202217:05GlobeNewswire Inc.Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
27/09/202217:05GlobeNewswire Inc.Avid Bioservices to Participate in RBC Global CDMO ConferenceNASDAQ:CDMOPAvid Bioservices Inc
22/09/202209:05GlobeNewswire Inc.Avid Bioservices Appoints Michael Alston, Jr. as Vice President, OperationsNASDAQ:CDMOPAvid Bioservices Inc
07/09/202217:05GlobeNewswire Inc.Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
06/09/202217:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
01/09/202209:05GlobeNewswire Inc.Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell BusinessNASDAQ:CDMOPAvid Bioservices Inc
30/08/202217:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022NASDAQ:CDMOPAvid Bioservices Inc
29/08/202217:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDMOPAvid Bioservices Inc
19/08/202218:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CDMOPAvid Bioservices Inc
29/06/202217:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
22/06/202217:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022NASDAQ:CDMOPAvid Bioservices Inc
14/06/202209:05GlobeNewswire Inc.Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing FacilityNASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP